These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28133873)

  • 21. Total IgE and allergen-specific IgE and IgG antibody levels in sera of atopic dermatitis affected and non-affected Labrador- and Golden retrievers.
    Lauber B; Molitor V; Meury S; Doherr MG; Favrot C; Tengvall K; Bergvall K; Leeb T; Roosje P; Marti E
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):112-8. PubMed ID: 22739207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy.
    Olivry T; Sousa CA
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):311-6. PubMed ID: 11553393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines.
    Hou CC; Griffin CE; Hill PB
    Vet Dermatol; 2008 Aug; 19(4):215-20. PubMed ID: 19086120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feline immunotherapy.
    Trimmer AM; Griffin CE; Rosenkrantz WS
    Clin Tech Small Anim Pract; 2006 Aug; 21(3):157-61. PubMed ID: 16933483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis.
    Wagner I; Geh KJ; Hubert M; Winter G; Weber K; Classen J; Klinger C; Mueller RS
    Vet Rec; 2017 Jul; 181(5):118. PubMed ID: 28526774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor?
    Ramió-Lluch L; Brazís P; Ferrer L; Puigdemont A
    Vet Rec; 2020 Dec; 187(12):493. PubMed ID: 33082241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergen-specific immunotherapy prescription patterns in veterinary practice: a US population-based cohort study.
    Tater KC; Cole WE; Pion PD
    Vet Dermatol; 2017 Aug; 28(4):362-e82. PubMed ID: 28164402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.
    Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
    van Amersfort K; Vernooij JCM; van der Lee A
    Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective survey of allergen immunotherapy in canine atopy.
    Nuttall TJ; Thoday KL; van den Broek AH; Jackson HA; Sture GH; Halliwell RE
    Vet Rec; 1998 Aug; 143(5):139-42. PubMed ID: 9725186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis.
    Schnabl B; Bettenay SV; Dow K; Mueller RS
    Vet Rec; 2006 Jan; 158(3):81-5. PubMed ID: 16428661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of serum total IgG1 concentration in atopic and non-atopic dogs.
    Fraser MA; McNeil PE; Gettinby G
    J Small Anim Pract; 2004 Apr; 45(4):186-90. PubMed ID: 15116886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis.
    Pucheu-Haston CM; Bizikova P; Eisenschenk MN; Santoro D; Nuttall T; Marsella R
    Vet Dermatol; 2015 Apr; 26(2):115-e30. PubMed ID: 25728611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study to identify perceived barrier and motivating factors of primary veterinarians in the USA for specialty referral and management of atopic dermatitis with allergen-specific immunotherapy.
    Flanagan S; Schick A; Lewis TP
    Vet Dermatol; 2020 Oct; 31(5):371-e98. PubMed ID: 32416025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the efficacy rate and time-to-efficacy of subcutaneous immunotherapy in dogs with atopic dermatitis.
    Tham HL; Olivry T
    Vet Dermatol; 2022 Apr; 33(2):155-e44. PubMed ID: 34883529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
    Marsella R
    Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.
    Mueller RS; Jensen-Jarolim E; Roth-Walter F; Marti E; Janda J; Seida AA; DeBoer D
    Allergy; 2018 Oct; 73(10):1989-1999. PubMed ID: 29675865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
    Colombo S; Hill PB; Shaw DJ; Thoday KL
    Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific immunotherapy of canine atopy. A prospective clinical study using tyrosine adsorbents].
    Münster M; Mitsch A
    Tierarztl Prax; 1996 Oct; 24(5):497-504. PubMed ID: 8999599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ACVD task force on canine atopic dermatitis (IX): the controversy surrounding the route of allergen challenge in canine atopic dermatitis.
    Olivry T; Hill PB
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):219-25. PubMed ID: 11553383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.